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research purposes, but not used for clinical decision making. 
Doses to the PTV, lung, heart and LAD were recorded. Four 
patient groups were identified for comparison: those who had 
at least one heart parameter worse with DIBH, minimal 
benefit arbitrarily defined as less than 20%, moderate benefit 
defined as between 20%-70% and a major benefit defined as 
greater than 70%. 
 
Results: Data was collected for a total of 70 patients. 
Overall, using DIBH, lung volume increased on average by 68% 
(range: 18.5% – 124.3%) while the heart volume in the 
treatment field was reduced by an average 69.5%. The LAD 
volume within the treatment field was reduced by 53%. The 
degree of benefit for heart and LAD doses is outlined in table 
1. 10% had at least one heart parameter worse with DIBH. 
Where the mean heart dose was higher all other heart 
constraints were worse. Five patients had an increase in the 
heart volume and maximum heart distance in the treatment 
field.  
 
 
 
Conclusion: Patients where DIBH was detrimental to heart 
dose constraints, no clear correlation could be drawn to 
identify this cohort of patients. Lung volume or percentage 
increase did not necessarily lead to more favourable 
outcomes, thus could not be used as a criteria for patient 
selection for DIBH. We aim to establish further predictive 
criteria in the second phase of this study. Until such time 
dual planning remains essential to identify patients who 
should not be offered DIBH. 
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Purpose or Objective: To establish whether photon or 
electron beams provide better dose coverage to tumour bed 
sites in different regions of the breast. 
 
Material and Methods: 10 patient data sets were selected 
from a trial cohort, 2 patients each with tumour beds in one 
of 5 regions within the breast – Superior Lateral Quadrant 
(SQL), Superior Medial Quadrant (SMQ), Inferior Lateral 
Quadrant (ILQ), Inferior Medial Quadrant (IMQ) and the 
Central Quadrant. The dose to the whole breast treatment of 
50Gy in 25 fractions was combined with a boost plan to the 
tumour bed of either photons or electrons with a dose of 
16Gy in 8 fractions. Dose to the PTV, lung, heart and breast 
tissues outside the tumour bed were assessed by using DVHs. 
 
Results: Tumours in the SLQ received better dose coverage 
by the photon boost plans. In all other areas of the breast the 
tumour bed coverage objectives were met with either 
photons or electrons.The target coverage in the combined 
plans was at least the same as or better than electrons with 
photon beams in all cases (Figure1). Electron beam coverage 
is dependent on surface contour regularity and tumour 
geometric shape, particularly if the PTV is not perpendicular 
to the skin surface and so requiring higher electron energies 
for PTV coverage at the deep margin. Lung had consistently 
lower doses with photon boost plans as the higher electron 
energies selected for target coverage in some plans increased 
lung dose (Figure2). The breast outside the tumour bed 
received lower doses with photon boosts. The heart doses 
were not consistently lower with either modality. 
 
 
 
Conclusion: Electrons were a less favourable modality for 
SLQ tumours, but either photons or electrons could be 
suitable for treating tumours in other regions of the breast in 
terms of target coverage and organ sparing. As photon boosts 
provided the same as or better coverage than electrons in 
combined plans, it would be feasible to use photons for all 
boosts. However, individualised planning is necessary to 
account for tumour position in relation to normal anatomy, 
surface contour and geometrical shaping of the tumour bed 
to optimise PTV coverage and organ sparing. If using 
electrons particular attention must be paid to the use of 
bolus for beams planned on irregular surface contours. 
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Purpose or Objective: This study was to quantify the 
reduced dose of right lung and right breast tissue by modified 
volumetric modulated arc therapy (MVMAT) for advanced 
left-side breast cancer including lymph node irradiation. 
 
Material and Methods: For all cases, the clinical target 
volume (CTV) consisted of the left breast, axillary lymph 
nodes, internal mammary chain lymph nodes, infraclavicular 
lymph nodes, and supraclavicular lymph nodes. 7 patients of 
MVMAT and 5 patients of volumetric modulated arc therapy 
(VMAT) were generated with the Eclipse Version11 treatment 
planning system. VMAT plans were generated using a five full 
rotation without avoidance sector. MVMAT plans were 
generated using a five partial rotation with avoidance 
sector.Two half arcs were for supraclavicular lymph nodes. 
Gantry angle started at 179 degree, stopped at 335 degree, 
and the 60-120 degree was set to be avoidance sector. 
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Gantry angle started at 181 degree, stopped at 35 degree, 
and the 240-300 degree was set to be avoidance sector. Two 
half arcs were for left-side breast and axillary nodes. Gantry 
angle started at 153 degree, stopped at 282 degree, and the 
0-90 angle was set to be avoidance sector. Gantry angle 
started at 282 degree, stopped at 161 degree, and the 0-90 
angle was set to be avoidance sector. One quarter arc was 
for internal mammary node. Gantry angle started at 179 
degree, stopped at 270 degree, and the 60-120 angle was set 
to be avoidance sector. The dose-volume-histogram were 
evaluated the target homogeneity and conformity and normal 
tissue tolerance dose. 
 
 
 
Results: MVMAT has significantly (p-value = 0.031) decreased 
right-side breast dose (V5Gy (%) = 39.9 ± 7.6), and has 
significantly (p-value = 0.005) decreased right lung dose 
(V5Gy (%) = 23.6 ± 7.3). Slightly less heart and left lung dose 
are found for MVMAT (heart V10Gy (%) = 45.7 ± 17.4, left lung 
V10Gy (%) = 48.6 ± 3.4) than in VMAT (heart V10Gy(%)=55.7 ± 
19.9, left lung V10Gy(%)=53.4 ± 5.1). MVMAT for advanced 
left-side breast cancer retains target homogeneity and 
coverage when compared to VMAT. 
 
 
 
Conclusion: MVMAT is suitable for advanced left-side breast 
cancer treatment. It retains target homogeneity and 
coverage and decreases the dose of right breast and right 
lung. 
 
OC-0168  
A simple visual test is adequate for testing vmDIBH 
reproducibility in locoregional breast cancer 
L.A. Den Otter
1Radiotherapiegroep, Radiotherapy, Deventer, The 
Netherlands 
1, T.T. Nuver1, M. Boerhof1, H.H. Kolkman-
Nijland1, W.J. Schoevers1, K. Muller1, A.W.H. Minken1 
 
Purpose or Objective: Voluntary moderately deep inspiration 
breath hold (vmDIBH) reduces the heart dose for 
radiotherapy of left-sided breast cancer patients. For 
locoregional breast cancer patients, the application of 
vmDIBH requires high reproducibility to assure the absence of 
gap or overlay between tangential breast fields and 
supraclavicular irradiation fields. 
In this study we present a simple and fast visual method to 
quantify movement around the junction of the tangential and 
supraclavicular fields. The simple method is evaluated by 
testing the target volume reproducibility using two 
consecutive CT-scans during vmDIBH. Heart position 
reproducibility is assessed as well, with the resulting 
dosimetric consequences. 
 
Material and Methods: For 80 consecutive breast cancer 
patients cranial-caudal (CC) displacement around the clavicle 
was quantified between five vmDIBHs. This was done in the 
CT room, before obtaining the planning CT scan. Intersecting 
CT laser lines were marked on tape and the maximum 
displacement was measured. This tape was positioned 
midclavicularly, with the horizontal laser lines on the 
junction line. 
For 19 patients who would be irradiated locoregionally, a 
second CT scan was additionally acquired. The CC 
displacement of the left clavicle between the two breath 
holds was quantified by contouring the clavicle in both CT 
scans, and rigid registration of the two volumes in ProSoma 
(v.3.3.266, Medcom, Darmstadt, Germany) virtual simulation 
software. 
The heart was delineated in both CT scans, excluding the 
great vessels. The two volumes were registered in ProSoma 
to measure CC, left-right (LR) and anterior-posterior (AP) 
displacements. Influence of the heart displacement on 
dosimetry was measured by superimposing the contoured 
heart volume of the second CT scan onto the treatment 
planning CT scan and calculating mean heart dose. 
 
Results: Results of the tape test show a mean CC 
displacement of 3.3 mm (range 0.5-8.0 mm) for the 
midclavicular region. For the two breath hold CT scans mean 
CC clavicle displacement was 1.1 mm (range 0.1 - 2.8 mm). 
The measured CC displacements of the tape test were for all 
19 locoregional patients larger than measured with CT. 
Mean difference in contoured heart volume was 3.7% (range 
0.5 - 11.2%). Mean heart dose differed on average 0.12 Gy 
(range 0.01 - 0.38 Gy), where planned mean heart dose 
varied between 0.59 and 3.58 Gy. Mean heart displacement 
was 1.7 mm (range 0-4.7 mm) CC, 1.5 mm (range 0.1-4.2 
mm) AP and 1.9 mm (range 0.1-6.9 mm) LR. 
 
 
Conclusion: A simple visual test is a good surrogate for CT 
scans in analyzing vmDIBH reproducibility. We showed that 
vmDIBH is reproducible with minimal gap or overlay between 
